对前100名心胸外科手术程序的医疗保险补偿的州变化,2013-2022年
Jack G Allen1, Carson Bateman2, Alexander Dorius1
1Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, USA.
Cureus
|October 28, 2024
概括
自2013年以来,医疗保险对心胸外科手术的补偿每年都在下降,并且州际差异很大. 某些手术,如起器和冠状动脉旁路移植手术,出现大幅下降,影响了医生实践地点的决定.
科学领域:
- 心血管外科心血管外科
- 卫生经济学 卫生经济学
- 公共卫生政策 公共卫生政策
背景情况:
- 医疗保险的报销率对于外科实践的可行性至关重要.
- 了解报销趋势对于医疗保健政策和医生分配至关重要.
- 由于医疗保健成本和政策的不断变化,心胸外科手术报销面临着严格的审查.
研究的目的:
- 分析2013年至2022年内心胸外科手术手术的医疗保险报销率的变化.
- 为了识别报销趋势的州际变化.
- 为了比较不同心胸手术组的报销变化.
主要方法:
- 对医疗保险和医疗补助服务中心数据库的分析,用于收益最高的心胸外科手术CPT代码 (2013-2022).
- 使用医疗保险行政承包商代码来确定州特定的报销.
- 使用消费者价格指数对支付的通货膨胀调整和基于收入的程序加权.
主要成果:
- 全国通货膨胀调整后医疗保险对顶级心胸手术的报销平均每年下降2.67%.
- 波多黎各,路易斯安那州和阿拉巴马州的报销变化最小;伊利诺伊州,堪萨斯州和怀俄明州的减少最大.
- 在心脏起器/除器手术和膜/冠状动脉绕道移植 (CABG) 手术之间发现的报销变化有显著差异.
结论:
- 对于心胸外科手术的报销模式在美国各州之间表现出显著的地理差异.
- 医疗保险报销的地理差异可能会影响医生实践地点的决定.
- 有针对性的游说策略可能是必要的,以解决退款下降的问题,并确保医疗保险受益人的优质护理.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Standards of Care II
635
Nurses bear specific legal responsibilities under several federal statutes, including:
635
Standards of Care I
669
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
669
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Peripheral Artery Disease III: Interprofessional Care
2
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
2


